Concepedia
Statistics
Publications
10
Citations
439
H-Index
Active since
2007
Affiliations
Amgen (United States)(Current)
University of California, Berkeley
University of California, Davis
San Francisco VA Medical Center
Andrew P. Marcus is an author at Amgen (United States) specializing in medicinal chemistry, pharmacology, and drug design.
Publications per year
2007–2016
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Michael G. Johnson, An‐Rong Li, Jiwen Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 105 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
Pronounced Steric Effects of Substituents in the Nazarov Cyclization of Aryl Dienyl Ketones
Andrew P. Marcus, Amy S. Lee, Rebecca L. Davis et al. · Angewandte Chemie International Edition · 2008 · 77 citations
Natural Sciences, Chemistry, Medicinal Chemistry +8
Synthesis of the Tetracyclic Core of Tetrapetalone A Enabled by a Pyrrole Reductive Alkyation
Andrew P. Marcus, Richmond Sarpong · Organic Letters · 2010 · 66 citations
Natural Sciences, Chemistry, Medicinal Chemistry +14
Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists
An‐Rong Li, Michael G. Johnson, Jiwen Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 43 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)
Jeffrey Varnes, Andrew P. Marcus, Russell C. Mauger et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 34 citations · Full text
Medicine, Neuroscience, Pharmacology +14
1–5 of 10